RNA Vaccine Design Against Ovarian Cancerous TP53 Neoantigen

Abstract: Ovarian cancer is a rare cancer, representing just 1.1% of all new cancer cases in the United States per year.  Likewise, approximately 1.2% of women are at risk of developing ovarian cancer during their lifetime, with most diagnoses made between 55-64 years...